Table 2. Study parameters for the present study.
Category | Parameter | Non-treated | Ivabradine-treated | P-value |
---|---|---|---|---|
Cardiovascular | Conscious HR [bpm] | 186±7.0§ | 157±9.3¶ | 0.03* |
Anesthesia HR [bpm] | 164±5.9§ | 140±6.4¶ | 0.03* | |
Systolic BP [mmHg] | 63±3.4§ | 71±7.9# | 0.27 | |
Diastolic BP [mmHg] | 45±3.4§ | 53±6.8# | 0.33 | |
Plaque burden | MR plaque size [mm2] | 11.0±0.9ll | 10.8±1.1¶ | 0.54 |
EvG intima size [mm2] | 6.80±1.03ll | 6.61±1.19¶ | 0.91 | |
Biomechanics | Absolute distension [mm] | 0.066±0.017§ | 0.064±0.018¶ | 0.84 |
Relative distension [%] | 1.9±0.4§ | 1.9±0.3¶ | 0.84 | |
Plaque vulnerability | AUC 7min [a.u.] | 791±60ll | 604±44¶ | 0.03* |
Ktrans [min-1] | 0.25±0.02ll | 0.17±0.02¶ | 0.04* | |
Microvessel density [mm-2] | 12.9±1.8ll | 9.8±1.8¶ | 0.40 | |
Relative lipid core size [%] | 1.7±0.4ll | 1.5±0.3¶ | 0.66 | |
Relative RAM11 [%] | 30.6±1.5ll | 17.2±2.9¶ | <0.01‡ |